Krungthai Card (KTC), a leading credit card issuer, expects the government's Easy E-Receipt tax rebate programme to help boost credit card spending in the first quarter of this year despite ...

The European Health Insurance Card (EHIC) provides EU/EEA citizens access to necessary medical care in 34 countries within Europe and Australia. The card is issued by the national insurance company or ...

BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase ... It offers an array of products including human diseases, animal health care products, and ...

Swiss pharma giant Novartis (NOVN: VX) has filed a lawsuit against the US Department of Health and Human Services (HHS) over a proposed cash rebate model. The model relates to the 340B program, which ...

For many long-time Yukoners, it can be the bulkiest card in their wallet. But starting this month, the territory is scrapping those blue health cards that have the ever-growing pile of renewal ...

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug ...

HHS told the Sec­ond Cir­cuit that Boehringer In­gel­heim’s vol­un­tary par­tic­i­pa­tion in Medicare ne­go­ti­a­tions “un­der­mines” its le­gal chal­lenge to the process.

13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on ...

Member of the Board of Managing Directors and Head of Human Pharma at Boehringer Ingelheim. “In the near future more can be expected. Our gratitude goes to the patients and clinical investigators ...